MARKET

KALA

KALA

Kala Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.550
-0.050
0.00%
Closed 16:24 09/20 EDT
OPEN
4.550
PREV CLOSE
4.550
HIGH
4.640
LOW
4.450
VOLUME
254.12K
TURNOVER
--
52 WEEK HIGH
11.01
52 WEEK LOW
3.500
MARKET CAP
154.73M
P/E (TTM)
-1.5999
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of KALA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

KALA News

  • Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
  • Business Wire.3d ago
  • Kala Still Has A Shot To Reach Its Goal For Approval After Latest Setback
  • Seeking Alpha - Article.08/29 15:38
  • Kala Pharmaceuticals to Present at Two Upcoming Investor Conferences in September
  • Business Wire.08/29 13:00
  • The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved
  • Benzinga.08/28 11:31

More

Industry

Biotechnology & Medical Research
+0.62%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About KALA

Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. The Company’s initial focus is on the treatment of eye diseases. The Company’s product candidate includes KPI-121 1%, KPI-121 0.25% and MPP rTKI Program. The Company has completed two Phase III clinical trials for KPI-121 1% . The KPI-121 0.25% is the Company’s product candidate for temporary relief of signs and symptoms of dry eye disease. KPI-121 1% is the twice-a-day product candidate for treatment of post-operative inflammation and pain following ocular surgery. MPP rTKI Program is therapies for retinal diseases that should be injected directly into the patient's eye, often at monthly intervals.
More

Webull offers Kala Pharmaceuticals Inc (KALA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.